Home » Health & Medicine » Global United Therapeutics Corporation Market to 2015,Analysis,Competitive Strategies and Forecasts,- Acute Market Reports
“This report provides comprehensive information on the current therapeutic developmental pipeline of United Therapeutics Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),”
Acute Market Reports include new market research report “Global Markets Directs, United Therapeutics Corporation Product Pipeline Review 2015, provides an overview of the United Therapeutics Corporations pharmaceutical research and development focus ” to its huge collection of research reports.

Global Markets Directs, United Therapeutics Corporation Product Pipeline Review 2015, provides an overview of the United Therapeutics Corporations pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of United Therapeutics Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Browse Full Report with Toc Visit: http://www.acutemarketreports.com/report/united-therapeutics-corporation-product-pipeline-review-2015

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.

The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

View all reports of this category @ http://www.acutemarketreports.com/category/pharmaceutical-market

Scope

  • The report provides brief overview of United Therapeutics Corporation including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of United Therapeutics Corporations human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the United Therapeutics Corporations pipeline products

Reasons to buy

  • Evaluate United Therapeutics Corporations strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of United Therapeutics Corporation in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the United Therapeutics Corporations R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of United Therapeutics Corporation and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of United Therapeutics Corporation
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of United Therapeutics Corporation and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Click Here To Download Detail Report: http://www.acutemarketreports.com/checkout/36714

Table of Contents 2

List of Tables 4

List of Figures 4

United Therapeutics Corporation Snapshot 5

United Therapeutics Corporation Overview 5

Key Information 5

Key Facts 5

United Therapeutics Corporation – Research and Development Overview 6

Key Therapeutic Areas 6

United Therapeutics Corporation – Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products – Monotherapy 9

Pipeline Products – Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

United Therapeutics Corporation – Pipeline Products Glance 12

United Therapeutics Corporation – Late Stage Pipeline Products 12

Pre-Registration Products/Combination Treatment Modalities 12

Phase III Products/Combination Treatment Modalities 13

United Therapeutics Corporation – Clinical Stage Pipeline Products 14

Phase I Products/Combination Treatment Modalities 14

United Therapeutics Corporation – Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

United Therapeutics Corporation – Drug Profiles 16

dinutuximab 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

beraprost sodium SR 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

PLX-PAD 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

UV-4B 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

esuberaprost sodium ER 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Human Antibody Based Vaccines 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

Insulin Producing Islet Cells 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

Small Molecules for Viral Infections 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

United Therapeutics Corporation – Pipeline Analysis 31

United Therapeutics Corporation – Pipeline Products by Target 31

United Therapeutics Corporation – Pipeline Products by Route of Administration 32

United Therapeutics Corporation – Pipeline Products by Molecule Type 33

United Therapeutics Corporation – Pipeline Products by Mechanism of Action 34

United Therapeutics Corporation – Recent Pipeline Updates 35

United Therapeutics Corporation – Dormant Projects 39

United Therapeutics Corporation – Discontinued Pipeline Products 40

Discontinued Pipeline Product Profiles 40

8H-9 40

Monoclonal Antibody to Target Ganglioside GD2 for Neuroblastom 40

UT-231B 40

United Therapeutics Corporation – Company Statement 41

United Therapeutics Corporation – Locations And Subsidiaries 44

Head Office 44

Other Locations & Subsidiaries 44

Browse All Reports Of This Publisher: http://www.acutemarketreports.com/publisher/global-markets-direct

About Acute Market Reports

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.  We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Media Contact
Company Name: Acute Market Reports
Contact Person: Chris Paul
Email: sales@acutemarketreports.com
Phone: +1-855-455-8662
Address:Office No 01, 1st Floor, Aditi Mall, Baner
City: Pune
State: Maharashtra
Country: India
Website: http://www.acutemarketreports.com/report/united-therapeutics-corporation-product-pipeline-review-2015

Comments are closed.